Alpharma Inc. (NYSE: ALO) reports Q1 EPS of $3.77 (including sale of Active Pharmaceuticals Ingredients business and its sale to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE